A Nottingham life sciences company that has been involved in processing thousands of daily Covid-19 tests is set to unveil plans for a £130m flotation.

Sky News says Source BioScience will raise up to £35m through a share issue that will be announced on Thursday.

Source Bioscience will use the cash double its testing capacity of 5,000 Covid-19 tests a day.

The company has been listed on the main market before, but was taken private in 2016 when it was bought by shareholders Harwood Capital and Continental Investment Partners -among others – in a £63m deal.

Source BioScience emloys 200 people and has its main laboratories on Nottingham Business Park. As well as Covid testing, it also carries out biopsy testing for the NHS and genomics and DNA testing, as well as storage for biotech companies.

The company also offers storage services for biotech companies.

Jay LeCoque, SourceBio International’s chief executive, told Sky News: “The IPO on AIM allows us to significantly increase our COVID-19 testing capacity, accelerate earnings growth in our core business and execute on potential M&A [merger and acquisition] opportunities.

“It’s an exciting time for our business and we’re delighted with the keen interest from investors we have seen so far.”

Original Article

Source Bioscience is a Patron of Medilink East Midlands.

For more information on Medilink EM Patronage, click here

Latest Opportunities

AI Airlock pilot call for applications

Funding competition information Following the launch webinar on 23 July 2024, candidates can now apply…

Explore the Chinese Market with EFEC

Lily Lin, CEO of Excellence First Enterprise Consultancy (EFEC), will be visiting China from 13…

Pioneer Group launches Golden Ticket Programme for cardiometabolic health innovations

Pioneer Group, a specialist in life science infrastructure and venture building, has teamed up with…

Latest News

Medilink Midlands’ Innovation Builder launches at Innovation Day 2024

On the 3rd of October 2024, over 250 guests, presenters and exhibitors attended Medilink Midlands’ annual…

TBAT Innovation announces 2024 Innovation Challenge Top 10 Finalists

The Innovation Challenge 2024, proudly presented by TBAT Innovation, with Headline Sponsor Shakespeare Martineau, has…

Pioneer Group launches Golden Ticket Programme for cardiometabolic health innovations

Pioneer Group, a specialist in life science infrastructure and venture building, has teamed up with…